The data show that up to 80% of people who are diagnosed with pancreatic cancer have either recently developed Type 2 diabetes or have prediabetes.
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback